Evaluation of 0.2 µg/day fluocinolone acetonide (ILUVIEN)...

Evaluation of 0.2 µg/day fluocinolone acetonide (ILUVIEN) implant in a cohort of previously treated patients with diabetic macular oedema (DMO): a 36-month follow-up clinical case series

Ahmed, Muna, Putri, Christine, Quhill, Hibba, Quhill, Fahd
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
5
Journal:
BMJ Open Ophthalmology
DOI:
10.1136/bmjophth-2020-000484
Date:
July, 2020
File:
PDF, 1.26 MB
2020
Conversion to is in progress
Conversion to is failed